Ortin Laboratories Limited
NSE: ORTINLAB
NSE
20.33
-0.04 (-0.20%)
Prev Close
20.37
Open Price
21.49
Volume
69,927
Today Low / High
20.27 / 21.88
52 WK Low / High
16.2 / 26.35
Range
19 - 21
Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 20.33, with a change of -0.04 (-0.1964%). The expected target range on the NSE is between 19 - 21. The stock is experiencing a downward trend on the NSE. Investors should be cautious as the price is currently declining.
Ortin Laboratories Limited Graph
Ortin Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Ortin Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 20.33, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 20.33 | 20.53 | 18.48 - 22.59 |
| 20.74 | 16.59 - 24.88 | ||
| 20.94 | 14.66 - 27.22 | ||
| Bearish Scenario | 20.33 | 20.13 | 18.11 - 22.14 |
| 19.92 | 15.94 - 23.91 | ||
| 19.72 | 13.80 - 25.64 |
Overview of Ortin Laboratories Limited
ISIN
INE749B01020
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
118,301
Market Cap
165,311,159
Last Dividend
0
Official Website
IPO Date
2015-08-21
DCF Diff
19.52
DCF
1
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 2.11 Cr | 4.51 Cr | -2.39 Cr | -1.1339 | 0.00 Cr | 0.00 Cr | -6.77 Cr | -8.04 Cr | -9.89 | -6.54 Cr | -3.8082 |
| 2023-03-31 | 6.02 Cr | 3.39 Cr | 2.63 Cr | 0.4370 | 0.00 Cr | 0.18 Cr | 0.27 Cr | -0.07 Cr | -0.08 | 0.54 Cr | -0.0111 |
| 2022-03-31 | 8.23 Cr | 4.65 Cr | 3.58 Cr | 0.4348 | 0.00 Cr | 0.14 Cr | 0.32 Cr | -0.40 Cr | -0.49 | 0.55 Cr | -0.0484 |
| 2021-03-31 | 8.17 Cr | 3.97 Cr | 4.20 Cr | 0.5141 | 0.00 Cr | 0.15 Cr | 0.96 Cr | 0.95 Cr | 1.16 | 1.30 Cr | 0.1158 |
| 2020-03-31 | 196.16 Cr | 160.22 Cr | 35.94 Cr | 0.1832 | 0.00 Cr | 0.75 Cr | 3.80 Cr | -0.56 Cr | -0.69 | 5.88 Cr | -0.0029 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 2.34 Cr | 6.66 Cr | 3.84 Cr | 2.8239 Cr | 1.80 Cr | -0.54 Cr | 0.05 Cr | 0.01 Cr | 0.00 Cr | 0.00 Cr | 0.23 Cr | 2.0381 Cr |
| 2023-03-31 | 0.22 Cr | 21.20 Cr | 10.33 Cr | 10.8649 Cr | 6.45 Cr | 6.23 Cr | 2.60 Cr | 14.39 Cr | 0.10 Cr | 3.10 Cr | 0.23 Cr | 6.9802 Cr |
| 2022-03-31 | 0.49 Cr | 20.70 Cr | 9.75 Cr | 10.9568 Cr | 6.14 Cr | 5.65 Cr | 1.74 Cr | 14.64 Cr | 2.41 Cr | 0.14 Cr | 0.21 Cr | 7.6102 Cr |
| 2021-03-31 | 0.03 Cr | 21.27 Cr | 9.91 Cr | 11.3555 Cr | 6.94 Cr | 6.92 Cr | 1.83 Cr | 14.81 Cr | 0.25 Cr | 0.18 Cr | 0.00 Cr | 7.8860 Cr |
| 2020-03-31 | 0.96 Cr | 116.52 Cr | 92.70 Cr | 23.8159 Cr | 27.53 Cr | 26.57 Cr | 49.90 Cr | 22.88 Cr | -22.63 Cr | 1.43 Cr | 0.07 Cr | 83.8271 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -4.1534 Cr | 11.5006 Cr | -3.0075 Cr | -4.1534 Cr | 2.0867 Cr | 2.3426 Cr | 0.0000 Cr | -8.0410 Cr | 0.0000 Cr | 0.0000 Cr | 2.5482 Cr |
| 2023-03-31 | -0.2445 Cr | -0.0020 Cr | 0.9040 Cr | -0.2465 Cr | 0.6575 Cr | -3.2656 Cr | -0.0020 Cr | -0.1105 Cr | 1.2333 Cr | 0.0000 Cr | -0.8574 Cr |
| 2022-03-31 | 2.1524 Cr | -0.1253 Cr | -0.4754 Cr | 2.0270 Cr | 1.5517 Cr | -3.9232 Cr | -0.1253 Cr | -0.5300 Cr | 0.2875 Cr | 0.0000 Cr | 0.0908 Cr |
| 2021-03-31 | 18.0343 Cr | 0.0696 Cr | -9.8587 Cr | 18.0343 Cr | 8.2452 Cr | -5.4749 Cr | 0.0000 Cr | 0.1365 Cr | -2.0659 Cr | 0.0000 Cr | 48.0689 Cr |
| 2020-03-31 | 6.2269 Cr | -3.0932 Cr | -4.2552 Cr | 3.1067 Cr | -1.1216 Cr | -13.7200 Cr | -3.1202 Cr | 0.7185 Cr | 1.8772 Cr | 0.0000 Cr | -12.9436 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 0.21 Cr | 0.15 Cr | 0.06 Cr | 0.2718 | -0.10 Cr | -0.10 Cr | -0.13 | -0.10 Cr | -0.4938 |
| 2024-03-31 | 0.14 Cr | 0.30 Cr | -0.15 Cr | -1.0477 | -3.27 Cr | -4.14 Cr | -5.10 | -3.22 Cr | -28.6243 |
| 2023-12-31 | 0.14 Cr | 2.58 Cr | -2.45 Cr | -17.8823 | -2.66 Cr | -2.79 Cr | -3.43 | -2.60 Cr | -20.4079 |
| 2023-09-30 | 0.26 Cr | 0.39 Cr | -0.13 Cr | -0.4933 | -0.96 Cr | -1.12 Cr | -1.38 | -0.90 Cr | -4.3157 |
| 2023-06-30 | 1.57 Cr | 0.71 Cr | 0.86 Cr | 0.5492 | 0.13 Cr | 0.02 Cr | 0.02 | 0.19 Cr | 0.0104 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 2.34 Cr | 0.00 Cr | 2.34 Cr | 1.77 Cr | 0.05 Cr | 6.34 Cr | 0.01 Cr | 6.66 Cr | 3.84 Cr |
| 2023-12-31 | -0.32 Cr | 0.63 Cr | 0.32 Cr | 0.00 Cr | 0.00 Cr | 0.32 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 0.32 Cr | 0.01 Cr | 0.33 Cr | 0.49 Cr | 2.49 Cr | 3.72 Cr | 14.27 Cr | 18.23 Cr | 8.47 Cr |
| 2023-06-30 | -0.26 Cr | 0.51 Cr | 0.26 Cr | 0.00 Cr | 0.00 Cr | 0.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-03-31 | 0.22 Cr | 0.04 Cr | 0.26 Cr | 3.42 Cr | 2.60 Cr | 6.54 Cr | 14.39 Cr | 21.20 Cr | 10.33 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | -4.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -2.79 Cr | 0.13 Cr | 0.00 Cr | 0.00 Cr | 0.13 Cr | 0.45 Cr | 0.33 Cr | 0.00 Cr | 0.13 Cr |
| 2023-09-30 | -1.12 Cr | 0.12 Cr | 0.00 Cr | 0.00 Cr | 0.12 Cr | 0.33 Cr | 0.21 Cr | 0.00 Cr | 0.12 Cr |
| 2023-06-30 | 0.02 Cr | 0.12 Cr | 0.00 Cr | 0.00 Cr | 0.12 Cr | 0.37 Cr | 0.26 Cr | 0.00 Cr | 0.12 Cr |
| 2023-03-31 | -0.20 Cr | 0.06 Cr | 0.00 Cr | 0.00 Cr | 0.06 Cr | 0.26 Cr | 0.19 Cr | 0.00 Cr | 0.06 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2021-01-12 | January 12, 21 | 12:25 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,640.90 | ₹3,936,978,552,000.00 | ₹1,313,620.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,100.50 | ₹1,619,493,634,500.00 | ₹394,932.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,617.80 | ₹1,224,426,321,000.00 | ₹287,405.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,253.40 | ₹1,043,245,022,805.00 | ₹1,191,889.00 |
| Mankind Pharma Limited | MANKIND | ₹2,466.00 | ₹1,017,789,122,160.00 | ₹376,033.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹988.60 | ₹994,758,978,000.00 | ₹1,911,246.00 |
| Lupin Limited | LUPIN | ₹1,989.80 | ₹908,835,180,600.00 | ₹875,748.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,388.50 | ₹644,276,002,500.00 | ₹899,623.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,078.20 | ₹626,220,716,400.00 | ₹444,368.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹2,029.30 | ₹572,670,489,300.00 | ₹466,363.00 |
| Laurus Labs Limited | LAURUSLABS | ₹863.15 | ₹465,949,948,750.00 | ₹2,817,579.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Cohance Lifesciences Limited | COHANCE | ₹986.05 | ₹377,230,198,238.00 | ₹177,879.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,364.60 | ₹346,204,478,400.00 | ₹113,365.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,671.70 | ₹333,791,511,200.00 | ₹40,260.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,715.50 | ₹268,163,529,000.00 | ₹62,276.00 |
| Piramal Enterprises Limited | PEL | ₹1,127.20 | ₹255,511,441,600.00 | ₹243,681.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,501.60 | ₹243,978,466,400.00 | ₹325,967.00 |
| Eris Lifesciences Limited | ERIS | ₹1,674.80 | ₹228,119,483,600.00 | ₹42,022.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,416.50 | ₹210,412,500,000.00 | ₹34,705.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹941.00 | ₹184,965,783,000.00 | ₹25,900.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,077.50 | ₹171,625,277,500.00 | ₹132,577.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,018.00 | ₹167,019,638,200.00 | ₹23,483.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,156.90 | ₹163,949,635,730.00 | ₹164,102.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹904.25 | ₹161,960,217,500.00 | ₹516,819.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹460.35 | ₹111,701,165,400.00 | ₹778,530.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,182.50 | ₹102,625,790,500.00 | ₹13,202.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹906.20 | ₹88,618,113,580.00 | ₹114,891.00 |
| Strides Pharma Science Limited | STAR | ₹867.30 | ₹79,941,382,710.00 | ₹568,013.00 |
| FDC Limited | FDC | ₹483.20 | ₹78,669,792,000.00 | ₹76,497.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹790.45 | ₹71,642,135,379.00 | ₹1,229,147.00 |
| Innova Captab Limited | INNOVACAP | ₹902.00 | ₹51,616,886,860.00 | ₹24,559.00 |
| Suven Life Sciences Limited | SUVEN | ₹232.25 | ₹50,647,686,500.00 | ₹235,893.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹142.28 | ₹46,172,990,160.00 | ₹192,243.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹488.05 | ₹44,544,323,500.00 | ₹79,719.00 |
| Sequent Scientific Limited | SEQUENT | ₹171.51 | ₹42,934,955,850.00 | ₹221,470.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹768.10 | ₹38,957,340,710.00 | ₹102,241.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,281.60 | ₹37,735,382,400.00 | ₹9,674.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹513.80 | ₹36,174,500,040.00 | ₹45,592.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹356.70 | ₹35,769,162,600.00 | ₹36,115.00 |
| Hikal Limited | HIKAL | ₹255.65 | ₹31,521,900,650.00 | ₹589,191.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹605.30 | ₹29,147,010,900.00 | ₹54,573.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹93.23 | ₹27,365,522,210.00 | ₹1,598,864.00 |
| Indoco Remedies Limited | INDOCO | ₹293.70 | ₹27,093,208,230.00 | ₹138,144.00 |
| Alembic Limited | ALEMBICLTD | ₹105.19 | ₹27,010,898,475.00 | ₹451,825.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹47.31 | ₹25,923,703,740.00 | ₹3,167,804.00 |
Key Executives
Chief Executive Officer & MD
Mr. Sanka Murali Krishna Murthy
Gender: male
Year Born: 1959
Chief Financial Officer & Whole Time Director
Mr. Sanka Srinivasa Kumar
Gender: male
Year Born: 1965
FAQs about Ortin Laboratories Limited
Who is the CEO of the company?
The CEO is Sanka Murali Krishna Murthy.
What is the current market price of the stock?
The current price is ₹20.33.
What is the 52-week price range?
The range is ₹16.2-26.35.
What is the market capitalization of the company?
The market capitalization is ₹16.53 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -2.35.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Ortin Laboratories Limited (ISIN: INE749B01020) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹16.53 crores and an average daily volume of 118,301 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.